- Generic name
- Rifampicin
- Strength
- 450 mg
- Dosage form
- Capsule
- Manufactured by
- Square Pharmaceuticals PLC.
Ifacin Capsule
About Ifacin 450 mg Capsule
Ifacin 450 mg Capsule, made by Square Pharmaceuticals PLC., contains rifampicin, an anti-tubercular antibiotic. It is used in the treatment of tuberculosis and the meningococcal carrier state, and it works by blocking RNA synthesis in susceptible bacteria.
There are 18 brands of Rifampicin listed in Bangladesh. The lowest listed price is Firifam 150 mg Tablet at ৳ 1 per unit.
What is Ifacin 450 mg Capsule?
Ifacin 450 mg Capsule is a prescription antibiotic manufactured by Square Pharmaceuticals PLC. The active ingredient is rifampicin, which belongs to a group of medicines called anti-tubercular antibiotics. Rifampicin works by interfering with the ability of certain bacteria to make RNA, which is essential for their growth. Ifacin is used in the treatment of tuberculosis and in the meningococcal carrier state. Because bacteria can become resistant, treatment is often given as part of a combination regimen and is guided by a doctor. The capsule is taken by mouth, but the exact dose and course are set by the doctor. Laboratory tests may be done before and during treatment to confirm the organism and check liver function.
Uses of Ifacin
Ifacin 450 mg Capsule is used in the treatment of tuberculosis, including all forms of the disease, and in the treatment of the meningococcal carrier state. It is an anti-tubercular antibiotic. In tuberculosis, it is usually part of a multi-drug regimen chosen by the doctor. It is not a treatment for viral infections or for infections caused by organisms that are not susceptible to rifampicin. The doctor will confirm the need for this medicine and decide how it fits into your overall treatment.
How to use Ifacin
Ifacin 450 mg Capsule is taken by mouth. The doctor decides the dose and how long you take it; follow their instructions exactly. The capsule is usually swallowed whole with a full glass of water. It is recommended that oral rifampicin be taken once daily, either one hour before or two hours after a meal. Do not stop taking it early, even if you feel better, because that can make the infection harder to treat. If you miss a dose, ask your doctor or pharmacist what to do.
Side effects of Ifacin
Common side effects of Ifacin 450 mg Capsule include facial flushing and itching, with or without a rash, and a flu-like syndrome with fever, chills, headache, dizziness, bone pain, shortness of breath, and malaise. Gastrointestinal effects such as nausea, vomiting, loss of appetite, diarrhoea, and stomach discomfort can occur. Rifampicin commonly causes an orange-red discolouration of urine, faeces, sweat, saliva, sputum, tears, and other body fluids; this is expected and not harmful. Other effects include changes in kidney function, menstrual disturbances, oedema, muscle weakness, and blood count changes. Serious effects are possible; tell your doctor about any side effect.
Safety and precautions
Ifacin 450 mg Capsule can affect the liver, and serious liver reactions have occurred, especially in people with liver disease or those taking other liver-toxic medicines. People with impaired liver function should receive rifampicin only if necessary, with caution and strict medical supervision, and liver function tests may be checked before and during treatment. Do not take this medicine if you have had an allergic reaction to rifampicin or other rifamycins. It must not be used with ritonavir-boosted saquinavir or with atazanavir, darunavir, fosamprenavir, saquinavir, or tipranavir. Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding; rifampicin taken in the last few weeks of pregnancy can cause bleeding in the mother and infant. Ask your doctor or pharmacist before use if you have any health concerns.
Frequently asked questions
What is Ifacin 450 mg Capsule used for and what kind of medicine is it?
Ifacin 450 mg Capsule is an anti-tubercular antibiotic containing rifampicin. It is used in the treatment of tuberculosis and the meningococcal carrier state. It works by blocking RNA synthesis in susceptible bacteria. It is a prescription medicine, so your doctor will decide if it is right for you.
How should Ifacin 450 mg Capsule be taken?
Take Ifacin 450 mg Capsule by mouth with a full glass of water. The doctor decides the dose and the length of the course; follow their instructions exactly. Oral rifampicin is usually taken once daily, either one hour before or two hours after a meal. Do not stop early without asking your doctor.
What medicines may interact with Ifacin 450 mg Capsule?
Ifacin can speed up the metabolism and reduce the effect of drugs broken down by CYP450 enzymes, such as quinidine, phenytoin, and theophylline. It may change levels of atovaquone, ketoconazole, and enalaprilat, and antacids can reduce its absorption. It raises the risk of liver toxicity with halothane or isoniazid. Tell your doctor or pharmacist about all medicines you take.
What should I know about pregnancy and breastfeeding with Ifacin?
Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding. Rifampicin taken during the last few weeks of pregnancy can cause bleeding in the mother and infant, and vitamin K treatment may be needed. For nursing mothers, the decision to continue or stop must be made with the doctor, considering the importance of the drug.
Also available as
Indications
Pharmacology
Dosage & Administration
Tuberculosis:
- Adults: 10 mg/kg, in a single daily administration, not to exceed 600 mg/day, oral or IV
- Pediatric Patients: 10–20 mg/kg, not to exceed 600 mg/day, oral or IV
Rifampin is indicated in the treatment of all forms of tuberculosis. A three-drug regimen consisting of rifampin, isoniazid, and pyrazinamide is recommended in the initial phase of shortcourse therapy which is usually continued for 2 months. The Advisory Council for the Elimination of Tuberculosis, the American Thoracic Society, and the Centers for Disease Control and Prevention recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (INH), rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of INH resistance is very low. The need for a fourth drug should be reassessed when the results of susceptibility testing are known. If community rates of INH resistance are currently less than 4%, an initial treatment regimen with less than four drugs may be considered.
Following the initial phase, treatment should be continued with rifampin and isoniazid for at least 4 months. Treatment should be continued for longer if the patient is still sputum or culture positive, if resistant organisms are present, or if the patient is HIV positive.
Interaction
Contraindications
Rifampin is contraindicated in patients who are also receiving atazanavir, darunavir, fosamprenavir, saquinavir, or tipranavir due to the potential of rifampin to substantially decrease plasma concentrations of these antiviral drugs, which may result in loss of antiviral efficacy and/or development of viral resistance.
Side Effects
Pregnancy & Lactation
Nursing Mothers: Because of the potential for tumorigenicity shown for rifampin in animal studies, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Precautions & Warnings
In some cases, hyperbilirubinemia resulting from competition between rifampin and bilirubin for excretory pathways of the liver at the cell level can occur in the early days of treatment. An isolated report showing a moderate rise in bilirubin and/or transaminase level is not in itself an indication for interrupting treatment; rather, the decision should be made after repeating the tests, noting trends in the levels, and considering them in conjunction with the patient's clinical condition.
Rifampin has enzyme-inducing properties, including induction of delta amino levulinic acid synthetase. Isolated reports have associated porphyria exacerbation with rifampin administration.
Overdose Effects
Liver enlargement, possibly with tenderness, can develop within a few hours after severe overdosage; bilirubin levels may increase and jaundice may develop rapidly. Hepatic involvement may be more marked in patients with prior impairment of hepatic function. Other physical findings remain essentially normal. A direct effect upon the hematopoietic system, electrolyte levels, or acid-base balance is unlikely.
Facial or periorbital edema has also been reported in pediatric patients. Hypotension, sinus tachycardia, ventricular arrhythmias, seizures and cardiac arrest were reported in some fatal cases.
Storage Conditions
Alternative brands of Rifampicin
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.